Advertisement

Topics

Sagres Discovery Company Profile

14:26 EST 20th November 2017 | BioPortfolio

Sagres Discovery is building a market position in oncology by applying innovative technologies to establish strong proprietary programs in oncogene discovery, molecular profiling, drug target validation, and therapeutic development.

According to the National Institutes of Health, annual costs related to cancer in the U.S. totaled $156.7 billion in 2001. Worldwide cancer mortality is estimated to be 6.2 million per year by the World Health Organization. Now that the biotechnology industry has entered the postgenomic era, attention has shifted to genes, proteins, and the biological pathways they control as the critical path to effective cancer prevention, diagnosis and treatment.



Pharmaceutical and biopharmaceutical companies are seeking a significant number of validated drug targets and leads from which they can develop new cancer drugs. As a consequence, there is a tremendous opportunity for early-stage biotechnology companies to identify cancer genes and convert them into drug targets and profiling arrays that will translate into novel therapeutics. Sagres Discovery is poised at the forefront of this effort.



Sagres Discovery is a new biotechnology startup located in Davis, California. The founders recognized a business opportunity for an independent company that could combine state-of-the-art genomic tools with robust in-vivo gene discovery tools to overcome the biological validation bottleneck inherent in most genomics-based disease gene discovery programs. The company's technology platform enables discovery and clinical validation of human cancer genes at unprecedented speed.

Location

2795 Second Street, Suite 400
Davis
CA
95616
United States of America

Contact

Phone: (530) 297 4700
Fax: (530) 297 4701
Email: info@sagresdiscovery.com


News Articles [219 Associated News Articles listed on BioPortfolio]

Sygnature Discovery partners on pancreatic cancer research

Sygnature Discovery, which claims to be the UK’s largest independent drug discovery expert and research…

BRIEF—UK’s Medicines Discovery Catapult in new AMR project

The Medicines Discovery Catapult, the UK government-backed body that seeks to speed drug discovery and…

Target class drug discovery

Selection of molecular targets based on disease understanding is a dominant paradigm in drug discovery. We argue that a focus on classes of targets with central roles in biology provides a complimenta...

The Current issue of “The view from here” is concerned with nanoscience in drug discovery.

The topic of this month’s newsletter from Drug Discovery Today is “nanoscience in drug discovery”

Pharmacophore modeling and applications in drug discovery: challenges and recent advances

The most downloaded article from Drug Discovery Today in Q2 2010 was by Sheng-Yong Yang and deals with the application of pharmacophore modeling to drug discovery.

InterMed Discovery: The World's Largest Natural Product Library

In this interview Fintan Walton talks to Mr Erik Metz, Head of Business Development at InterMed Discovery - a Natural Product lead discovery company from Dortmund, Germany. Erik Metz explains how Inte...

Unique collaboration opportunities available for UK SMEs working on drug discovery

Medicines Discovery Catapult, a new national centre established to support innovative drug discovery, is inviting UK SMEs working in medicines to collaborate on high-resolution analysis.

A Groundbreaking Astronomy Discovery Gave Scientists Their Best Look Ever at How Gold Was Created

"There are many, many extraordinary discoveries within the discovery"

PubMed Articles [560 Associated PubMed Articles listed on BioPortfolio]

Protac-induced Protein Degradation in Drug Discovery: Breaking the Rules - or Just Making New Ones?

Targeted protein degradation, using bifunctional small molecules (Protacs) to remove specific proteins from within cells, has emerged as a novel drug discovery strategy with the potential to offer the...

The Utility of Target-Based Discovery.

18F-FDG silicon photomultiplier PET/CT: A pilot study comparing semi-quantitative measurements with standard PET/CT.

To evaluate if the new Discovery Molecular Insights (DMI) PET/CT scanner provides equivalent results compared to the standard of care PET/CT scanners (GE Discovery 600 or GE Discovery 690) used in our...

Three-Dimensional Cell Culture: A Rapidly Emerging Approach to Cellular Science and Drug Discovery.

From machine learning to deep learning: progress in machine intelligence for rational drug discovery.

Machine intelligence, which is normally presented as artificial intelligence, refers to the intelligence exhibited by computers. In the history of rational drug discovery, various machine intelligence...

Clinical Trials [146 Associated Clinical Trials listed on BioPortfolio]

Discovery Elbow Multi-Center Prospective Study

The purpose of this prospective clinical trial is to document the performance and clinical outcomes of Biomet Discovery Elbow.

A Clinical Investigation of the Discovery™ Elbow System

The purpose of this study is to perform a five-year, multi-center prospective evaluation of the Discovery™ Elbow System for outcome and durability. Relief of pain and restoration of fun...

Endometriosis Biomarker Discovery Study

This is a prospective, Single time point, discovery study intending to identify biomarkers that can differentiate endometriosis from other underlying reasons for pelvic pain. Patients unde...

Protein Biomarker Discovery and Validation in Chronic Obstructive Pulmonary Disease (COPD) And Asthma

The purpose of the study is to better understand the function of asthma and COPD, and response to therapy. There are two Phases to this study broken into two arms. In Phase I, our propose ...

Biologic Basis of Liver Cancer From Chronic Hepatitis B

The focus of the study is to identify viral factors and host immune responses that differentiate HBV-related HCC patients from HBV patients who have not progressed to HCC. To that end, the...

Companies [1065 Associated Companies listed on BioPortfolio]

Sagres Discovery

Sagres Discovery is building a market position in oncology by applying innovative technologies to establish strong proprietary programs in oncogene discovery, molecular profiling, drug target validati...

Discovery Health

Discovery Health Media includes the Discovery Health and FitTV television networks and online assets, including www.discoveryhealth.com, as well as its Continuing Medical Education (CME) business and ...

Argenta Discovery Ltd.

Argenta Discovery is a privately held drug discovery company, applying its integrated medicinal chemistry, biology, ADMET and CADD expertise to drive drug discovery programmes. Argenta has a successfu...

Pyxis Discovery B.V.

The ambition of Pyxis Discovery is to be the preferred chemistry service provider for companies that are active in small molecule drug discovery. Pyxis Discovery's Smart approach of designing and ...

Med Discovery SA

Med Discovery’s mission is the discovery and development of highly specific protein drugs to treat uro-genital cancers. By combining biological drug discovery expertise with a strong in-house knowle...

More Information about "Sagres Discovery" on BioPortfolio

We have published hundreds of Sagres Discovery news stories on BioPortfolio along with dozens of Sagres Discovery Clinical Trials and PubMed Articles about Sagres Discovery for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Sagres Discovery Companies in our database. You can also find out about relevant Sagres Discovery Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...


Corporate Database Quicklinks



Searches Linking to this Company Record